Use of informative prior distributions from mepolizumab data to support depemokimab PKPD model analysis

PAGE 31 (2023) Abstr 10456
Barceló C, Tanneau L, Acharya C, Ribbing J, Zecchin C, Schalkwijk S.
ConferenceInflammationPharmacometricsSpecial considerations

Pharmetheus Affiliates

Portrait-of-Catalina-Barcelo_Pharmetheus
Director, MIDD Consultant

Catalina Barceló

See bio
Portrait-of-Lenaig-Tanneau_Pharmetheus
Director, MIDD Consultant

Lénaïg Tanneau

See bio
Portrait-of-Chayan-Acharya_Pharmetheus
Senior Director, MIDD Consultant

Chayan Acharya

See bio
Portrait-of-Jakob-Ribbing_Pharmetheus-1
Principal Director, MIDD Consultant & Senior Expert

Jakob Ribbing

See bio